Currently out of the existing stock ratings of Dewey Steadman, 40 are a BUY (68.97%), 18 are a HOLD (31.03%).

Dewey Steadman

Work Performance Price Targets & Ratings Chart

Analyst Dewey Steadman, carries an average stock price target met ratio of 48.73% that have a potential upside of 19.68% achieved within 224 days. Previously, Dewey Steadman worked at CANACCORD.

Dewey Steadman’s has documented 113 price targets and ratings displayed on 10 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on AERI, Aerie Pharmaceuticals at 11-Jun-2019.

Wall Street Analyst Dewey Steadman

Analyst best performing recommendations are on INSM (INSMED).
The best stock recommendation documented was for INSM (INSMED) at 1/2/2019. The price target of $20 was fulfilled within 5 days with a profit of $6.03 (43.16%) receiving and performance score of 86.33.

Average potential price target upside

of $12.21 (19.8%) on ANIP (ANI PHARMACEUTICALS).
of $10.59 (21.25%) on AERI (AERIE PHARMACEUTICALS).
of $10.19 (45.78%) on INSM (INSMED).

AERI Aerie Pharmaceuticals ANIP ANI Pharmaceuticals ENDP Endo International PLC MNK Mallinckrodt plc PCRX Pacira Pharmaceuticals PRGO Perrigo Company PLC PRTK Paratek Pharmaceuticals INSM Insmed LPCN Lipocine SVRA Savara

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Yigal Nochomovitz (CITI)